A detailed history of Arizona State Retirement System transactions in Nuvation Bio Inc. stock. As of the latest transaction made, Arizona State Retirement System holds 42,788 shares of NUVB stock, worth $120,662. This represents 0.0% of its overall portfolio holdings.

Number of Shares
42,788
Previous 37,829 13.11%
Holding current value
$120,662
Previous $110,000 10.91%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$2.3 - $3.83 $11,405 - $18,992
4,959 Added 13.11%
42,788 $98,000
Q2 2024

Aug 05, 2024

BUY
$2.58 - $3.69 $97,598 - $139,589
37,829 New
37,829 $110,000
Q3 2023

Nov 06, 2023

BUY
$1.26 - $2.1 $778 - $1,297
618 Added 1.84%
34,265 $45,000
Q2 2023

Aug 01, 2023

SELL
$1.56 - $1.84 $1,555 - $1,834
-997 Reduced 2.88%
33,647 $60,000
Q1 2023

Apr 27, 2023

BUY
$1.6 - $2.48 $1,486 - $2,303
929 Added 2.76%
34,644 $57,000
Q4 2022

Feb 07, 2023

BUY
$1.68 - $2.5 $2,118 - $3,152
1,261 Added 3.89%
33,715 $64,000
Q3 2022

Nov 07, 2022

SELL
$0.29 - $4.04 $2 - $28
-7 Reduced 0.02%
32,454 $73,000
Q2 2022

Jul 28, 2022

BUY
$3.24 - $5.85 $9,801 - $17,696
3,025 Added 10.28%
32,461 $105,000
Q1 2022

May 04, 2022

BUY
$4.6 - $8.83 $1,223 - $2,348
266 Added 0.91%
29,436 $155,000
Q4 2021

Feb 04, 2022

SELL
$7.75 - $10.05 $26,636 - $34,541
-3,437 Reduced 10.54%
29,170 $248,000
Q3 2021

Nov 12, 2021

BUY
$7.78 - $10.0 $1,688 - $2,170
217 Added 0.67%
32,607 $324,000
Q2 2021

Aug 02, 2021

BUY
$9.22 - $14.48 $298,635 - $469,007
32,390 New
32,390 $302,000

Others Institutions Holding NUVB

About Nuvation Bio Inc.


  • Ticker NUVB
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 217,244,000
  • Market Cap $613M
  • Description
  • Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...
More about NUVB
Track This Portfolio

Track Arizona State Retirement System Portfolio

Follow Arizona State Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arizona State Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on Arizona State Retirement System with notifications on news.